Wed, 29 Jan 2025 | MBO/MBI
Digitised dental laboratory MediMatch has undergone a management buy-out (MBO).
MediMatch serves more than 2,000 dentists nationally with services such as crowns and dental implants and products such as scanners and milling machines. According to its most recent set of accounts at Companies House the business has around 30 employees.
The business, which also has a presence in Europe with labs in Dublin, Milan and Paris, has been growing at 20 per cent per year over the past three years thanks to its digital-first approach in a highly fragmented UK market.
The MBO was backed by private equity group Queen's Park Equity (QPE), which is focused on providing capital and expertise to high-quality, entrepreneur-led businesses within the Healthcare & Pharma, Education and Tech Enabled Business Services sectors, with strong ambition to accelerate their growth.
It believes that the dental sector in the UK and EU is ripe for even more consolidation.
It said the market is also benefit ting from an increase in privately funded dental treatments and the acceleration of the use of intra-oral scanners by dentists globally.
Hugo Van Loenen, MediMatch founder and CEO, said: "I'm thrilled to be partnering with QPE on this exciting journey. Their sector expertise and buy & build capability will be invaluable as we look to execute our accelerated growth plan over the coming years."
Jonny Kay, Managing Partner at QPE added: "This most recent investment further highlights the strength of our thematic-led research and origination capabilities and counts another directly sourced investment partnership for Fund I."
Sami Igout, Investing at QPE said he was keen to support Van Loenen and the MediMatch team to build on the impressive organic growth it has achieved in recent years.
"Their success is testament to both the quality and speed at which they serve their customers due to their digital-led approach. We look forward to supporting Hugo on the next phase of growth," Igout said.
Find out why MBOs are becoming more popular
This is an exciting opportunity to acquire a well-established community pharmacy in Cambridgeshire that has been independently operating for over 20 years with a 40-hour contract.
LEASEHOLD
This well-established and modern pharmacy in the West Midlands boasts over two decades of success and a strategic location with potential to enhance OTC and services revenue.
This long-established Cardiff pharmacy is experiencing consistent turnover growth, benefiting from a 5% NHS funding increase in Wales.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.